A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 38/19 (2006.01) A61K 38/20 (2006.01) C07K 14/245 (2006.01) C07K 14/34 (2006.01) C07K 14/54 (2006.01) C07K 14/55 (2006.01) C07K 19/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2103258
2103258 9220364 PCTABS00017 The invention features a method for treating meoplastic cell growth in a patient, wherein the meoplastic cell is of non-lymphoid and non-monocytic origin. The method includes administering to the patient a molecule which is capable of specifically binding to a cytokine receptor expressed on the meoplastic cell, which molecule is capable of decreasing the viability of the meoplastic cell. The cytokine receptor is a receptor normally expressed on cells of lymphoid or monocytic origin.
Poisson Louis R.
Waters Cory A.
Ridout & Maybee Llp
Seragen Inc.
LandOfFree
Cytokine receptor targeted molecules for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytokine receptor targeted molecules for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytokine receptor targeted molecules for treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1454988